- Conditions
- Herpangina, Gingivostomatitis, Hand, Foot and Mouth Disease
- Interventions
- Sucralfate, Placebo, Acetaminophen, Ibuprofen
- Drug · Other
- Lead sponsor
- University of Texas at Austin
- Other
- Eligibility
- 6 Months to 5 Years
- Enrollment
- 102 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 1
- States / cities
- Austin, Texas
Source: ClinicalTrials.gov public record
Updated Oct 28, 2021 · Synced May 21, 2026, 11:39 PM EDT